GLP-1R Agonist Liraglutide Activates Cyt
โ
Noyan-Ashraf, M. H.; Momen, M. A.; Ban, K.; Sadi, A.-M.; Zhou, Y.-Q.; Riazi, A.
๐
Article
๐
2009
๐
American Diabetes Association
๐
English
โ 370 KB
## OBJECTIVE Glucagon-like peptide-1 receptor (GLP-1R) agonists are used to treat type 2 diabetes, and transient GLP-1 administration improved cardiac function in humans after acute myocardial infarction (MI) and percutaneous revascularization. However, the consequences of GLP-1R activation before